Your browser doesn't support javascript.
loading
Efficacy of Osimertinib in Patients with Lung Cancer Positive for Uncommon EGFR Exon 19 Deletion Mutations.
Grant, Michael J; Aredo, Jacqueline V; Starrett, Jacqueline H; Stockhammer, Paul; van Alderwerelt van Rosenburgh, Iris K; Wurtz, Anna; Piper-Valillo, Andrew J; Piotrowska, Zofia; Falcon, Christina; Yu, Helena A; Aggarwal, Charu; Scholes, Dylan; Patil, Tejas; Nguyen, Christina; Phadke, Manali; Li, Fang-Yong; Neal, Joel; Lemmon, Mark A; Walther, Zenta; Politi, Katerina; Goldberg, Sarah B.
Afiliación
  • Grant MJ; Department of Medicine (Section of Medical Oncology), Yale School of Medicine, New Haven, Connecticut.
  • Aredo JV; Department of Medicine (Oncology), Stanford University, Stanford, California.
  • Starrett JH; Department of Medicine, University of California San Francisco School of Medicine, San Francisco, California.
  • Stockhammer P; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.
  • van Alderwerelt van Rosenburgh IK; Department of Medicine (Section of Medical Oncology), Yale School of Medicine, New Haven, Connecticut.
  • Wurtz A; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.
  • Piper-Valillo AJ; Department of Pharmacology, Yale School of Medicine, New Haven, Connecticut.
  • Piotrowska Z; Yale Cancer Biology Institute, West Haven, Connecticut.
  • Falcon C; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.
  • Yu HA; Department of Medicine (Hematology/Oncology), Massachusetts General Hospital, Boston, Massachusetts.
  • Aggarwal C; Department of Medicine (Hematology/Oncology), Massachusetts General Hospital, Boston, Massachusetts.
  • Scholes D; Department of Medicine (Thoracic Oncology), Memorial Sloan Kettering Cancer Center, New York, New York.
  • Patil T; Department of Medicine (Thoracic Oncology), Memorial Sloan Kettering Cancer Center, New York, New York.
  • Nguyen C; Department of Medicine (Division of Hematology/Oncology), University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.
  • Phadke M; Department of Medicine (Division of Hematology/Oncology), University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.
  • Li FY; Department of Medicine (Division of Medical Oncology), University of Colorado School of Medicine, Aurora, Colorado.
  • Neal J; Department of Medicine (Division of Medical Oncology), University of Colorado School of Medicine, Aurora, Colorado.
  • Lemmon MA; Yale Center for Analytical Sciences, Yale School of Public Health, New Haven, Connecticut.
  • Walther Z; Yale Center for Analytical Sciences, Yale School of Public Health, New Haven, Connecticut.
  • Politi K; Department of Medicine (Oncology), Stanford University, Stanford, California.
  • Goldberg SB; Department of Pharmacology, Yale School of Medicine, New Haven, Connecticut.
Clin Cancer Res ; 29(11): 2123-2130, 2023 06 01.
Article en En | MEDLINE | ID: mdl-36913537
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article